PDF herunterladen
CC BY 4.0 · Glob Med Genet 2022; 09(02): 185-188
DOI: 10.1055/s-0042-1743258
Rapid Communication

Mannose-Binding Lectin 2 Gene Polymorphism during Pandemic: COVID-19 Family

Tufan Tukek
1   Department of Internal Medicine, Faculty of Medicine, Istanbul University, Istanbul, Turkey
,
Sacide Pehlivan
2   Department of Medical Biology, Faculty of Medicine, Istanbul University, Istanbul, Turkey
,
Yasemin Oyaci 
2   Department of Medical Biology, Faculty of Medicine, Istanbul University, Istanbul, Turkey
,
Ummuhan Isoglu-Alkac
3   Department of Physiology, Faculty of Medicine, Istanbul University, Istanbul, Turkey
› Institutsangaben
Funding None.
› Weitere Informationen
Auch verfügbar auf
  Lizenzen und Reprints

Abstract

Mannose-binding lectin 2 (MBL2) is a serine protease which is believed to be an important factor in the inherited immune system. In this article, we present a coronavirus disease 2019 (COVID-19) family of five patients: a 56-year-old father, a 51-year-old mother, two sons aged 23 and 21 years, and a 15-year-old daughter. According to the results of MBL2 rs1800450 variant analysis performed, the father had homozygous mutant, the mother had homozygous normal, and the three children had heterozygous mutant genotype. When we compared the clinical parameters and genotypes, MBL2 gene polymorphism plays a very important role in COVID-19 susceptibility and severe disease. The family, which makes up our study, is the proof of this situation, and it contains important implications for host factors and COVID-19.

Keywords

COVID-19 - mannose-binding lectin 2 - polymorphism

Availability of Data and Materials

The authors declare that data supporting the findings of this study are available within the referenced articles.


Ethical Approval and Consent to Participate

Ethical committee approval was received (Faculty of Medicine, Istanbul University, approval date and number: 21/05/2020-84539) and a written consent was obtained from all patients for both sampling and publishing. The experimental procedures were based on the Declaration of Helsinki and relevant institutional regulations.




Publikationsverlauf

Eingereicht: 09. Dezember 2021

Angenommen: 29. Dezember 2021

Artikel online veröffentlicht:
25. Februar 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Cai Q, Chen F, Wang T, Luo F, Liu X, Wu Q. et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care 2020; 43 (07) 1392-1398
    CrossrefPubMedSuche in Google Scholar
  • 2 Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX. et al; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus Disease 2019 in China. N Engl J Med 2020; 382 (18) 1708-1720
    CrossrefPubMedSuche in Google Scholar
  • 3 Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S. et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020; 180 (07) 934-943
    CrossrefPubMedSuche in Google Scholar
  • 4 Jacobson S, Larsson P, Åberg AM, Johansson G, Winsö O, Söderberg S. Levels of mannose-binding lectin (MBL) associates with sepsis-related in-hospital mortality in women. J Inflamm (Lond) 2020; 17: 28
    CrossrefPubMedSuche in Google Scholar
  • 5 Best LG, Ferrell RE, Decroo S, North KE, Maccluer JW, Zhang Y. et al. Genetic and other factors determining mannose-binding lectin levels in American Indians: the Strong Heart Study. BMC Med Genet 2009; 10: 5
    CrossrefPubMedSuche in Google Scholar
  • 6 Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 2003; 37 (11) 1496-1505
    CrossrefPubMedSuche in Google Scholar
  • 7 Medetalibeyoglu A, Bahat G, Senkal N, Kose M, Avci K, Sayin GY. et al. Mannose binding lectin gene 2 (rs1800450) missense variant may contribute to development and severity of COVID-19 infection. Infect Genet Evol 2021; 89: 104717
    CrossrefPubMedSuche in Google Scholar
  • 8 Sumiya M, Super M, Tabona P, Levinsky RJ, Arai T, Turner MW. et al. Molecular basis of opsonic defect in immunodeficient children. Lancet 1991; 337 ;(8757): 1569-1570
    CrossrefPubMedSuche in Google Scholar
  • 9 Madsen HO, Garred P, Kurtzhals JA, Lamm LU, Ryder LP, Thiel S. et al. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 1994; 40 (01) 37-44
    CrossrefPubMedSuche in Google Scholar
  • 10 Di Maria E, Latini A, Borgiani P, Novelli G. Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis. Hum Genomics 2020; 14 (01) 30
    CrossrefPubMedSuche in Google Scholar
  • 11 Zhang H, Zhou G, Zhi L, Yang H, Zhai Y, Dong X. et al. Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection. J Infect Dis 2005; 192 (08) 1355-1361
    CrossrefPubMedSuche in Google Scholar
  • 12 Ip WK, Chan KH, Law HK, Tso GH, Kong EK, Wong WH. et al. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis 2005; 191 (10) 1697-1704
    CrossrefPubMedSuche in Google Scholar